A study published in the journal International Immunopharmacology found that egg yolk antibodies were effective in neutralizing the SARS-CoV-2 virus with a 75.86% success rate and could potentially be used in spray formulations to prevent the virus from spreading through the respiratory, oral, and digestive tracts.
After gaining millions of dollars in BioNTech investments, coincidently the partner for Pfizer's mRNA vaccines, Bill Gates decreased his shares in the company by 86%.
The move would re-organize the federal handling of the virus, so it is treated as a common threat to public health that can be handled through the usual powers of agencies.